Voices of Leadership Video Series

Our company is pivoting from a build phase to one of durable growth. Who are the leaders driving our key commercial areas?* What makes Amneal uniquely equipped to succeed in each? And what’s next? Some of our leaders share their candid thoughts below in these recent conversations…

Chirag and Chintu Patel Video Transcript (opens in a new window)
Andy Boyer Video Transcript (opens in a new window)

Shyamakant Giri Video Transcript (opens in a new window)
Joe Renda Video Transcript

Tasos Konidaris Video Transcript
Nikita Shah Video Transcript

Srinivas Kone, PhD Video Transcript

*Important note - as of March 1, 2024, Amneal has three reportable business segments:
1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).